Gene: APOBEC3B
Official Full Name: apolipoprotein B mRNA editing enzyme catalytic subunit 3Bprovided by HGNC
Gene Summary: This gene is a member of the cytidine deaminase gene family. It is one of seven related genes or pseudogenes found in a cluster, thought to result from gene duplication, on chromosome 22. Members of the cluster encode proteins that are structurally and functionally related to the C to U RNA-editing cytidine deaminase APOBEC1. It is thought that the proteins may be RNA editing enzymes and have roles in growth or cell cycle control. A hybrid gene results from the deletion of approximately 29.5 kb of sequence between this gene, APOBEC3B, and the adjacent gene APOBEC3A. The breakpoints of the deletion are within the two genes, so the deletion allele is predicted to have the promoter and coding region of APOBEC3A, but the 3' UTR of APOBEC3B. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33075 | APOBEC3B Knockout cell line (HeLa) | Human | APOBEC3B | 1:3~1:6 | Negative | Online Inquiry |
KO33076 | APOBEC3B Knockout cell line (HCT 116) | Human | APOBEC3B | 1:2~1:4 | Negative | Online Inquiry |
KO33077 | APOBEC3B Knockout cell line (HEK293) | Human | APOBEC3B | 1:3~1:6 | Negative | Online Inquiry |
KO33078 | APOBEC3B Knockout cell line (A549) | Human | APOBEC3B | 1:3~1:4 | Negative | Online Inquiry |
APOBEC3B Gene Knockout Cell Lines are sophisticated cellular models engineered to lack the APOBEC3B gene, a critical component known for its role in antiviral defense as well as in the mutagenesis of viral genomes and human DNA. These knockout cell lines allow researchers to study the multifaceted functions of APOBEC3B, particularly its implications in cancer biology and viral infection dynamics.
Functionally, these cell lines offer a controlled environment to investigate the consequences of APOBEC3B gene inactivation. The loss of this gene can lead to enhanced viral replication rates and altered mutation profiles, enabling researchers to dissect the mechanisms through which APOBEC3B mediates its effects at a molecular level. Furthermore, by utilizing gene editing techniques such as CRISPR/Cas9, these knockout models ensure precise and reproducible results, vital for downstream applications.
In the context of research and clinical applications, these cell lines serve as invaluable tools for cancer researchers studying the mutagenic potential of APOBEC3B in tumorigenesis, as well as immunologists exploring viral interactions with the host defense system. They hold significance in understanding disease mechanisms and therapeutic responses, such as the development of resistance to antiviral treatments.
One of the primary advantages of using APOBEC3B Gene Knockout Cell Lines is their specificity and reliability compared to other gene knockouts, which may not accurately mimic the complete biological ramifications of gene loss. Additionally, these custom-engineered cell lines are designed to demonstrate minimal phenotypic changes, thus maintaining the integrity of experimental results across diverse applications.
For researchers, clinicians, and biopharmaceutical developers, the value of APOBEC3B Gene Knockout Cell Lines lies in their potential to elucidate the roles of genetic factors in disease processes, ultimately guiding the development of targeted therapies. Leveraging our expertise in molecular biology and cell line development, we ensure our products meet the highest standards of accuracy and quality, empowering science to make impactful discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.